FrancophonIA/ELRC3.0 huggingface dataset:
English: The CHMP noted that fibrin sealants have the potential to be life-saving in certain circumstances, and that applying these medicines by spray is considered to be of benefit when there is a large surface area of bleeding during certain surgical procedures.
Maltese: Is-CHMP innota li f'ċerti ċirkostanzi s-siġillanti tal-fibrina għandhom il-potenzjal li jsalvaw il-ħajja, u li lapplikazzjoni ta' dawn il-mediċini bi sprej hija kkunsidrata ta' benefiċċju meta jkun hemm superfiċje kbira ta' fsada matul ċerti proċeduri kirurġiċi.
English: • the company for Evicel and Quixil should ensure that these products are used with pressure regulators that do not exceed the maximum pressure required to deliver the fibrin sealant, and that contain labels stating the recommended pressure and distance.
Maltese: • il-kumpanija għal Evicel u Quixil għandha tiżgura li dawn il-prodotti jintużaw b'regolaturi tal pressjoni li ma jaqbżux il-pressjoni massima meħtieġa biex jitwassal is-siġillant tal-fibrina, u li jkun fihom tikketti li jiddikjaraw il-pressjoni u d-distanza rakkomandata.
English: Based on the evaluation of the currently available data and the scientific discussion within the Committee, the CHMP concluded that the benefits of Evicel and Quixil continue to outweigh their risks, but that further risk minimisation measures should be implemented when these medicines are given by spray application to ensure that they are used correctly.
Maltese: Abbażi tal-evalwazzjoni tad-dejta disponibbli attwalment u d-diskussjoni xjentifika fil-Kumitat, is-CHMP ikkonkluda li l-benefiċċji ta' Evicel u Quixil jkomplu jegħlbu r-riskji tagħhom, imma li għandhom jiġu implimentati aktar miżuri ta' minimizzazzjoni tar-riskji meta dawn il-mediċini jingħataw b'applikazzjoni sprej biex jiġi żgurat li jintużaw kif suppost.
English: The fibrin then aggregates (sticks together) and forms a fibrin clot that helps the wound to heal, stopping the bleeding.
Maltese: Il-fibrina mbagħad tingħaqad (teħel flimkien) u tifforma embolu tal-fibrina li tgħin lill-ferita tfieq, u twaqqaf il-fsada.
English: The solution is currently sprayed using either pressurised air or carbon dioxide (CO2).
Maltese: Attwalment is-soluzzjoni tiġi sprejjata jew permess tal-arja jew biddijossidu tal-karbonju (CO2) taħt pressjoni
English: When the two solutions are mixed together, thrombin breaks fibrinogen up into smaller units called fibrin.
Maltese: Meta ż-żewġ soluzzjonijiet jitħalltu flimkien, thrombin ikisser lil fibrinogen f'unitajiet iżgħar msejħa fibrina.
English: This indicates that the risk minimisation measures have not been sufficient.
Maltese: Dan jindika li l-miżuri ta' minimizzazzjoni tar-riskji ma kinux biżżejjed.
English: The full changes made to the product information for Evicel are detailed here, and for Quixil here.
Maltese: It-tibdil sħiħ għall-informazzjoni dwar il-prodott għal Evicel qiegħed jingħata fid-dettall hawn, u għal Quixil hawn.
English: • Evicel or Quixil application by spray should only be considered if it is possible to accurately judge the spraying distance.
Maltese: kienu jinvolvu Evicel jew Quixil applikati bi sprej.
English: Hungary Zoetis Hungary Kft. Alkotás u. 53.
Maltese: L-Ungerija Zoetis Hungary Kft. Alkotás u. 53.
English: de Europa 20B Parque empresarial La Moraleja 28108 Alcobendas, Madrid Spain
Maltese: Avda. de Europa 20B Parque empresarial La MOralieja 28108 Alcobendas, Madrid Spanja
English: FI 00330 Helsinki Finland
Maltese: FI 00330 Helsinki Il-Finlandja
English: Denmark Zoetis Finland Oy Tietokuja 4
Maltese: Zoetis Finland Oy Tietokuja 4
English: Member State EU/EEA
Maltese: Membru UE/ŻEE
English: B-2870 Puurs Belgium
Maltese: B-2870 Puurs
English: Zoetis Portugal, Lda Lagoas Park, Edifício 10 2740-271 Porto Salvo Portugal
Maltese: Zoetis Portugal, Lda Lagoas Park, Edifício 10 2740-271 Porto Salvo Il-Portugall
English: Rivium Westlaan 74, 2909 LD Capelle a/d Ijssel The Netherlands
Maltese: Westlaan 74, 2909 LD Capelle a/d Ijssel L-Olanda
English: 2012 Sep 21;54:54.
Maltese: Acta Vet Scand. 2012 Sett 21;54:54.
English: H-1123 Budapest Hungary
Maltese: H-1123 Budapest L-Ungerija
English: Postępu 17B 02-676 Warszawa Poland
Maltese: 02-676 Warszawa
English: ATCvet code: QJ01FF52.
Maltese: QJ01FF52.
English: Ireland Pfizer Healthcare Ireland Trading as Pfizer Animal Health,
Maltese: L-Irlanda Pfizer Healthcare Ireland Trading as Pfizer Animal Health,
English: Via Andrea Doria, 41 M 00192 Roma Italy
Maltese: S.r.l. Via Andrea Doria, 41 M 00192 Roma L-Italja
English: Zoetis UK Limited 5th Floor, 6 St. Andrew Street
Maltese: Zoetis UK Limited 5th Floor, 6
English: Pfizer Manufacturing Belgium N.V.
Maltese: L-Estonja Pfizer Manufacturing Belgium N.V.
English: EC4A 3AE London United Kingdom
Maltese: EC4A 3AE London Ir-Renju Unit
English: Overdose (symptoms, emergency procedures, antidotes):
Maltese: Doża eċċessiva (sintomi, proċeduri ta' emerġenza, antidoti)
English: Volume (L) for 150 g of the veterinary medicinal product
Maltese: Volume (L) għal 150 g talprodott mediċinali veterinarju =
English: Excipients: Sodium benzoate, lactose.
Maltese: Sodium benzoate, lactose.
English: Zoetis Österreich GmbH Floridsdorfer Hauptstraße 1 1210 Vienna
Maltese: L-Awstrija Zoetis Österreich GmbH Floridsdorfer Hauptstraße 1 1210 Vienna
English: Discussion of data available
Maltese: Diskussjoni tad-dejta disponibbli
English: The oral absorption of lincomycin was found to be 53% ± 19%.
Maltese: L-assorbiment orali ta' linkomiċina nstab li kien 553% ± 19%.
English: Zoetis Polska Sp. z o.o.
Maltese: Il-Polonja Zoetis Polska Sp. z o.o. ul.
English: Zoetis Hellas SA L. Mesogion 253- 255 15451, N. Psichico Athens
Maltese: Zoetis Hellas SA L. Mesogion 253- 255 15451, N.
English: LincoSpectin 100 prašek za peroralno raztopino za prašiče in perutnino
Maltese: LincoSpectin 100 prašek za perOralino raztopino za prašiče in perutnino
English: LINCOSPECTIN Polvere orale per uso in acqua da bere per polli da carne e suini
Maltese: LINCOSPECTIN Polvere Oralie per uso in acqua da bere per polli da carne e suini
English: Slovakia Zoetis Česká republika, s.r.o.
Maltese: Is-Slovakkja Zoetis Česká republika, s.r.o.
English: 150 g of powder = 100 g antibiotic activity should be diluted in…
Maltese: 150 g ta' trab = 100 g t'attività antibijotika għandha tkun dilwita f'...
English: Indirect benefits
Maltese: Benefiċċji indiretti
English: Incompatibilities:
Maltese: Inkompatibilitajiet
English: Lincomycin
Maltese: Linkomiċina
English: Romania Pfizer Animal Health MA EEIG
Maltese: Il-Latvija Pfizer Animal Health MA EEIG
English: There is no established clinical breakpoint.
Maltese: M'hemm ebda breakpoint kliniku stabbilit.
English: 1348 Louvain-la-Neuve Belgium
Maltese: 1348 Louvain-la-Neuve Il-Belġju
English: Water consumption
Maltese: Konsum ta' ilma
English: Pringle et al. (2012)1 have proposed an epidemiological cut-off of >1 μg/ml for lincomycin, with which 90 to 100% of the isolates are classified as “resistant in vitro”.
Maltese: Pringle et al. 2012).1 ipproponew cut-off epidemjoloġiku ta' >1 μg/ml għal lincomycin, li permezz tiegħu, 90 sa 100% tal-iżolati huma kklassifikati bħala “reżistenti in vitro”.
English: Peak serum levels were observed at 4 hours after dosing.
Maltese: L-ogħla livelli fis-serum kienu osservati sa 4 sigħat wara li ngħatat id-doża.
English: Meat and offal: 5 days.
Maltese: Laħam u ġewwieni: 5 ijiem
English: LINCO SPECTIN 100 plv.
Maltese: LINCO SPECTIN 100 plv. sol.
English: Chickens (broilers)
Maltese: Tiġieġ (brojlers)
English: Linco-Spectin 100 is a powder for oral solution containing 33.3 g lincomycin (as lincomycin hydrochloride) and 66.7 g spectinomycin (as spectinomycin sulphate) per 150 g pack.
Maltese: Linco-Spectin 100 huwa trab għal soluzzjoni orali li fih 33.3 g lincomycin (bħala lincomycin hydrochloride) u 66.7 g spectinomycin (bħala spectinomycin sulphate) għal kull pakkett ta' 150 g.
English: 2 Goren E, de Jong WA, Doornenbal P. Therapeutic efficacy of medicating drinking water with spectinomycin and lincomycin-spectinomycin in experimental Escherichia coli infection in poultry.
Maltese: Therapeutic efficacy of medicating drinking water with spectinomycin and lincomycinspectinomycin in experimental Escherichia coli infection in poultry.
English: June http://www.who.int/foodsafety/foodborne_disease/AGISAR_2009_report_final.pdf?ua=1
Maltese: 3 Report of the first meeting of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR), 15-19 June 2009. http://www.who.int/foodsafety/foodborne_disease/AGISAR_2009_report_final.pdf?ua=1
English: Co. Cork
Maltese: Cork
English: Pharmacotherapeutic group: antibacterials for systemic use, lincomycin combinations.
Maltese: Grupp farmak-terapewtiku: antibatterjali għal użu sistemiku, kombinazzjonijiet ta' linkomiċina.
English: Among in vitro susceptibility data for M. gallisepticum, a new MIC survey of lincomycin-spectinomycin (1:2 ratio) was carried out on 60 isolates, and showed a MIC range of [0.25:0.5 - 8:16 µg/ml], and MIC50/MIC90 values of 0.5:1 and 2:4 µg/ml, respectively.
Maltese: Fost dejta dwar is-suxxettibbiltà in vitro għal M. gallisepticum, sar stħarriġ ġdid tal-MIC ta' linkomiċinaspettinomiċina (proporzjon ta' 1:2) fuq 60 iżolat, u dan wera medda tal-MIC ta' [0.25:0.5 - 8:16 µg/ml], u valuri tal-MIC50/MIC90 ta' 0.5:1 u 2:4 µg/ml, rispettivament.
English: The symptoms disappeared within 5 to 8 days without interruption of the treatment.
Maltese: Is-sintomi sparixxew fi żmien 5 sa 8 ijiem mingħajr waqfien tat trattament.
English: Spectinomycin is classified as an aminocyclitol antibiotic, close to aminoglycosides; it inhibits protein synthesis by binding to the 30S ribosomal subunit.
Maltese: Spectinomycin huwa kklassifikat bħala antibijotiku aminocyclitol qrib aminoglycosides; jinibixxi s-sinteżi tal-proteini billi jeħel mas-sottounità ribosomali 30S.
English: Regarding B. hyodysenteriae, including the points already mentioned, several issues were identified:
Maltese: Fir-rigward ta' B. hyodysenteriae, inkluż ilpunti diġà msemmija, ġew identifikati diversi kwistjonijiet:
English: The activity spectrum of spectinomycin includes mycoplasmas, aerobic gramnegative bacteria, and gram-positive cocci.
Maltese: L-ispettru ta' attività ta' spectinomycin jinkludi mikoplażmi, batterji aerobiċi gram-negattivi, u kokki gram-pożittivi.
English: Poultry (broilers)
Maltese: Qżieqes Tjur (brojlers)
English: Lithuania Zoetis Belgium SA Rue Laid Burniat 1
Maltese: Il-Litwanja Zoetis Belgium SA Rue Laid Burniat 1
English: Zoetis BV
Maltese: L-Olanda Zoetis BV Rivium
English: NAME OF THE VETERINARY MEDICINAL PRODUCT <Invented name> 222 mg/g + 444.7 mg/g powder for use in drinking water lincomycin (as lincomycin hydrochloride)/spectinomycin (as spectinomycin sulphate).
Maltese: VETERINARJU <Isem ivvintat> 222 mg/g + 444.7 mg/g trab għall-użi fl-ilma għax-xorb linkomiċina (bħala idrokloridu tal-linkomiċina)/spektinomiċina (bħala sulfat tal-ispektinomiċina).
English: Slovenia Zoetis Belgium SA, Rue Laid Burniat 1, 1348 Louvain-la-Neuve Belgium
Maltese: Is-Slovenja Zoetis Belgium SA, Rue Laid Burniat 1, 1348 Louvain-la-Neuve Il-Belġju
English: MLS antimicrobials are listed by WHO (AGISAR, 2009)3 as critically important for the treatment of certain zoonotic infections in humans (such as Campylobacter infections).
Maltese: L-antimikrobiċi tal-MLS huma elenkati mid-WHO (AGISAR, 2009)3 bħala ta' importanza kritika għall-kura ta' ċerti infezzjonijiet żoontiċi fil-bniedem (bħal infezzjonijiet Campylobacter).
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports).
Maltese: kura waħda) - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal) - mhux komuni (aktar minn wieħed iżda inqas minn 10 annimali f'1,000 annimal) - rari (aktar minn wieħed iżda inqas minn 10 annimali f'10,000 annimal) - rari ħafna (inqas minn animal wieħed f'10,000 animal, inklużi rapporti iżolati).
English: Similar results were observed following single oral doses of 4.4 and 11.0 mg/kg body weight in pigs.
Maltese: Riżultati simili kienu osservati wara dożi orali waħdenin ta' 4.4 u 11.0 mg/kg piż tal-ġisem fil-qżieqeż.
English: SP, Powder for oral solution for chickens
Maltese: SP, Trab għal soluzzjoni Orali for Tiġieġ
English: Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve Belgium
Maltese: Zoetis Belgium SA Rue Laid Burniat, 1 1348 Louvain-la-Neuve Il-Belġju
English: Sodium benzoate Lactose
Maltese: 6.1 Lista ta' ingredjenti Sodium benzoate Lactose
English: Older field studies typically used a dose regimen of 150 mg/kg bw in a first phase followed by 50 mg/kg bw in a second phase; they were considered poorly relevant as they focus on systematic prophylaxis and zootechnical/economical endpoints.
Maltese: Studji eqdem fuq il-post normalment użaw skema tad-dożaġġ ta' 150 mg/kg bw fl-ewwel fażi segwita minn 50 mg/kg bw fit-tieni fażi; tqiesu ftit li xejn relevanti peress li jiffokaw fuq profilassi sistematika u punti aħħarin żootekniċi/ekonomiċi.
English: Powder for oral solution.
Maltese: Trab għal soluzzjoni orali.
English: Despite the poor in vitro activity of the active substances against L. intracellularis, the combination might be effective due to combined intra- and extracellular action of lincomycin and spectinomycin, respectively.
Maltese: Minkejja l-attività in vitro batuta tas-sustanzi attivi kontra L. intracellularis, it-taħlita tista' tkun effettiva minħabba azzjoni kombinata intra u extraċellolari ta' linkomiċina u spettinomiċina, rispettivament.
English: Tolerance is still adequately reflected by the harmonised texts for SPC sections 4.5 (i) Special precautions for use in animals, 4.6 Adverse reactions (frequency and seriousness) and 4.10 Overdose.
Maltese: It-tolleranza għadha riflessa b'mod adegwat mit-testi armonzizati għat-taqsimiet tal-SPC 4.5 (i) Prekawzjonijiet speċjali għall-użu f'annimali, 4.6 Reazzjonijiet avversi (frekwenza u gravità) u 4.10 Doża eċċessiva.
English: Pharmacodynamic properties.
Maltese: Proprjetajiet farmakodinamiċi.
English: Linco-Spectin 100 (and associated names) is a powder for use in drinking water containing the active substances lincomycin (222 mg/g) and spectinomycin (444.7 mg/g).
Maltese: Linco-Spectin 100 (u ismijiet assoċjati) huwa trab li għandu jintuża f'ilma tajjeb għax-xorb li fih issustanzi attivi linkomiċina (222 mg/g) u spettinomiċina (444.7 mg/g).
English: Pigs: LincoSpectin 100
Maltese: LincoSpectin 100
English: Chickens Oral
Maltese: Qżieqes Orali
English: On 28 September 2012, Belgium sent a referral notification under Article 34(1) of Directive 2001/82/EC, as amended, to the CVMP/European Medicines Agency for Linco-Spectin 100 and its associated names.
Maltese: Fit-28 ta' Settembru 2012, il-Belġju bagħat notifika ta' riferiment skont l-Artikolu 34(1) tadDirettiva 2001/82/KE, kif emendata, lis-SVMP/Aġenzija Ewropea għall-Mediċini għal Linco-Spectin 100 u ismijiet assoċjati tiegħu.
English: In the new MIC survey using 25 isolates from Belgium, a lincomycinspectinomycin MIC range of 1:2 to 32:64 µg/ml was obtained, with a MIC50 of 16:32 and a MIC90 of 32:64 µg/ml.
Maltese: 32:64 µg/ml, b'MIC50 ta' 16:32 u MIC90 ta' 32:64 µg/ml.
English: Poultry (broilers, pullets and turkeys)
Maltese: Qżieqes Tjur (brojlers, għattuq u dunsjani)
English: It is mainly active against Gram-positive bacteria and obligate anaerobes, and against mycoplasmas.
Maltese: Huwa attiv prinċipalment kontra l-batterji Gram-pożittivi u obligate anaerobes, u kontra l-mikoplażmi.
English: Lay:
Maltese: Qżieqeż:
English: Belgium Zoetis Belgium SA Rue Laid Burniat, 1
Maltese: Il-Bulgarija Zoetis Belgium SA Rue Laid Burniat 1
English: Clinical efficacy against proliferative enteropathy is substantiated through one GLP laboratory study and one GCP multicenter field study, except that in the laboratory study the animals were treated for 21 days.
Maltese: L-effikaċja klinika kontra enteropatija proliferattiva hija sostanzjata permezz ta' studju tal-laboratorju tal-GLP u studju multiċentru fuq il-post tal-GCP, ħlief li fl-istudju tal-laboratorju l-annimali ngħataw ilkura għal 21 jum.
English: Spectinomycin has no significant clinical effect on B. hyodysenteriae.
Maltese: Spectinomycin ma għandu ebda effett kliniku sinifikanti fuq B. hyodysenteriae.
English: In this study the MIC range was from 4:8 µg/ml up to ≥256:512, with high MIC90 values of >256 µg/ml for spectinomycin, and a seemingly bimodal distribution.
Maltese: 512, b'valuri MIC90 għoljin ta' >256 µg/ml għal spectinomycin, u distribuzzjoni apparentement bimodali.
English: Pigs Poultry
Maltese: Qżieqes Tjur
English: The product is used in the proposed indications (swine dysentery and proliferative enteropathy) for several decades in many EU Member States, on the basis of the complementary activity spectra of lincomycin and spectinomycin on the primary pathogens B. hyodysenteriae and L. intracellularis and the potentially associated enteric pathogens such as E. coli.
Maltese: Il-prodott jintuża fl-indikazzjonijiet proposti (disinterija tal-majjali u enteropatija proliferattiva) għal bosta deċenni f'ħafna Stati Membri tal-UE, fuq il-bażi tal-ispettri tal-attività komplimentari ta' linkomiċina u spettinomiċina fuq il-patoġeni primarji B. hyodysenteriae u L. intracellularis u l-patoġeni enteriċi potenzjalment assoċjati bħal E. coli.
English: Literature and the proprietary old in vitro susceptibility data show that the overall lincomycin minimum inhibitory concentration (MIC) range for B. hyodysenteriae is very wide and the population MIC50 and MIC90 values are high.
Maltese: Id-dokumenti u d-dejta dwar is-suxxettibilità in vitro antika proprjetarja juru li l-medda ta' konċentrazzjoni inibitorja globali minima ta' lincomycin (MIC) B. hyodysenteriae hija wiesgħa ħafna u valuri tal-MIC50 u MIC90 tal-popolazzjoni huma għolja.
English: Rare cases of irritability/excitation, skin rash/pruritus were also observed.
Maltese: Każijiet rari ta' irritabilità/eċitazzjoni, raxx tal-ġilda/ħakk kienu osservati wkoll.
English: This could be due to combined intra- and extracellular action of lincomycin and spectinomycin, respectively.
Maltese: Dan jista' jkun minħabba azzjoni intra-u extraċellulari kkombinata ta' lincomycin u spectinomycin, rispettivament.
English: Route of administration
Maltese: U METODU TA' AMMINISTRAZZJONI
English: For the treatment and prevention of chronic respiratory disease (CRD) caused by Mycoplasma gallisepticum and Escherichia coli, and associated with a low mortality rate.
Maltese: Għat-trattament u l-prevenzjoni ta‘ mard respiratorju kroniku (chronic respiratory disease, CRD) ikkaġunat minn Mycoplasma gallisepticum u Escherichia coli, u assoċjat ma‘ rata ta‘ mortalità baxxa.
English: Taking into account the scope of this Article 34 referral procedure, the proposed indication for L. intracellularis in pigs was deemed acceptable.
Maltese: Filwaqt li titqies l-applikazzjoni ta' din il-proċedura ta' riferiment tal-Artikolu 34, l-indikazzjoni proposta għal L. intracellularis fil-majjali kienet meqjusa aċċettabbli.
English: Chickens:
Maltese: Qżieqes:
English: It has little or no action against gram-negative bacteria such as Escherichia coli.
Maltese: Ftit li xejn għandha azzjoni kontra batterja gram-negattivi bħal Eschaeria coli.
English: The combination might have a synergistic effect in Mycoplasma, but the clinical significance of this was not investigated.
Maltese: It-taħlita jista' jkollha effett sinerġistiku f'Mycoplasma, iżda l-importanza klinika ta' dan ma ġietx investigata.
English: 0.1 L/kg bw/day
Maltese: 0.1 L/kg piż tal ġisem/jum
English: Chickens: 16.65 mg lincomycin and 33.35 mg spectinomycin/kg bw/day, for 7 days.
Maltese: Tiġieġ 16.65 mg linkomiċina u 33.35 mg spektinomiċina /kg piż tal-ġisem/jum, għal 7 ijiem.
English: 2,000 x [daily water consumption per bird (L)] average body weight of one bird (kg)
Maltese: 2,000 x [konsum ta' ilma kuljum għal kull tajra (L)] piż tal-ġisem medju ta' tajra waħda (kg)
English: Italy
Maltese: ZOETIS ITALIA
English: Lincomycin is active against gram-positive bacteria, some anaerobic gram-negative bacteria (such as Brachyspira hyodysenteriae) and mycoplasmas.
Maltese: Linkomiċina hija attiva kontra batterja gram-pożittivi, xi batteriċi anerobiċi gram negattivi (bħal Brachyspira hyodysenteriae) u mikoplasmi.
English: Lincomycin is a lincosamide antibiotic derived from Streptomyces lincolnensis which inhibits protein synthesis.
Maltese: Il-Linkomiċina hija antibijotiku ta' linkosamidu derivat minn Streptomyces lincolnensis li jimpedixxi s-sintesi ta' proteini.
English: The veterinary medicinal product should be used based on antimicrobial susceptibility testing.
Maltese: Il-prodott mediċinali veterinarju għandu jkun użat biss abbażi ta' testijiet ta' suxxetibilità antimikrobjali.
English: Pigs: 3.33 mg lincomycin and 6.67 mg spectinomycin/kg bw/day, for 7 days.
Maltese: Qżieqeż 3.33 mg linkomiċina u 6.67 mg spektinomiċina /kg piż tal-ġisem/jum, għal 7 ijiem.
English: 150 g of the veterinary medicinal product corresponds to the dose for 2,000 kg of body weight per day.
Maltese: 150 g ta' prodott mediċinali veterinarju jikkorispondi għad-doża għal 2,000 kg ta' piż tal-ġisem kuljum.
English: Linco-Spectin 100 Soluble Powder, Powder for Oral Solution
Maltese: Linco-Spectin 100 Soluble Powder, Trab għal soluzzjoni Orali
English: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Maltese: Fin-nuqqas ta' studju dwar kompatibilità, dan il-prodott mediċinali veterinarju ma jistax jintuża flimkien ma' prodotti mediċinali veterinarji oħra.
English: Germany Zoetis Deutschland GmbH Schellingstraße 1,
Maltese: Il-Ġermanja Zoetis Deutschland GmbH Schellingstraße 1, D-10785 Berlin Il-Ġermanja
English: Resistance to lincomycin is frequently conferred by plasmid-borne factors (erm genes) coding for methylases modifying the ribosomal binding site and frequently leading to cross-resistance to other antimicrobials of the MLSb group.
Maltese: Ir-reżistenza għal linkomiċina hija frekwentement ikkonferita minn fatturi marbuta minn plasmids (ġeni erm ) li jikkodifikaw għal methylases billi jimmodifikaw s-sit ta' rbit ribożomali u frekwentament iwasslu għal antimikrobjali oħra tal-grupp MLSb.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals)
Maltese: - mhux komuni (aktar minn wieħed iżda inqas minn 10 annimali f'1,000 annimal) - rari (aktar minn wieħed iżda inqas minn 10 annimali f'10,000 annimal) - rari ħafna (inqas minn animal wieħed f'10,000 animal, inklużi rapporti iżolati).
English: For E. coli, a newly conducted pan-European MIC survey, involving 67 chicken isolates and 33 turkey isolates, showed a wide MIC range (from 2:4 to ≥256:512 µg/ml), a high spectinomycin MIC90 (256 µg/ml) and a bimodal distribution.
Maltese: Għal E. coli, stħarriġ tal-MIC pan-Ewropew li għadu kif isir, li involva 67 tiġieġa iżolata u 33 dundjan iżolat, wera medda wiesgħa tal-MIC (minn 2:4 għal ≥256:
English: Also, information as to widespread decreased susceptibility in B. hyodysenteriae and as to the bimodal distribution in E. coli should be added to section 5.1.
Maltese: Barra minn hekk, għandha tiżdied l-informazzjoni dwar suxxettibilità mnaqqsa mifruxa f'B. hyodysenteriae u dwar id-distribuzzjoni bimodali f'E. coli mas-sezzjoni 5.1.
English: Pharmacokinetic particulars
Maltese: GĦAMLA FARMAĊEWTIKA
English: 1,500 L of drinking water
Maltese: 1,500 L ta' ilma għax-xorb